What drugs were reviewed in the update of the guideline?
Drugs reviewed in the update included: Mineralocorticoid receptor antagonists, Beta-blockers in people with with CHF and atrial fibrillation, Treating heart failure in people with chronic kidney disease, Iron supplementation.